Apixaban (Eliquis): Essential Insights for Safe Anticoagulation

This presentation provides an overview of Apixaban (Eliquis), a Direct Oral Anticoagulant (DOAC). It covers its clinical uses, including nonvalvular atrial fibrillation, deep vein thrombosis, pulmonary embolism, and postsurgical prophylaxis, as well as its mode of action via selective Factor Xa inhibition. Detailed guidance on dosing, administration, and important safety considerations, such as monitoring bleeding risks and drug interactions, will also be discussed. Emphasis is placed on...